Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III). (Q30317994)
scientific article
Language:
Current Data About Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).
(P31) (Q13442814)
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(P50) (Q38803238)
(P1545) 2
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(Q82068372)
(P1545) 4
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(Q30957829)
(P1545) 8
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(Q46772644)
(P1545) 9
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(Q96189852)
(P1545) 1
(P1932) Hans-Joachim Schmoll
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(P304) 3588-3595
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(P407) (Q1860)

(P433) 29
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(P478) 30
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(P577) Monday, September 10, 2012
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(P921) (Q188874)
(P887)

(Q413299)
(P887)

(Q25493920)
(P887)

(P1433) (Q400292)
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(P1476) "Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III)" (language: en)
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

(P2093) Alberto Sobrero
(P1545) 3
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

Philippe Rougier
(P1545) 5
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

Sheryl L Koski
(P1545) 6
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

Ilona Kocakova
(P1545) 7
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

Paul Mainwaring
(P1545) 10
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

Ramon Salazar
(P1545) 11
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

Peter Barker
(P1545) 12
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

Bijoyesh Mookerjee
(P1545) 13
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

Jane Robertson
(P1545) 14
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

Eric Van Cutsem
(P1545) 15
(P248)
(P698) 22965961
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22965961%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, February 12, 2020

other details
description scientific article

External Links
(P356) 10.1200/JCO.2012.42.5355
(P698) 22965961